Labcorp EVP granted 6,382 shares; 2,722 withheld

LABCORP HOLDINGS INC. executive Sandra D. van der Vaart, EVP, Corporate Affairs, received a grant of 6,382 shares of common stock on March 26, 2026.

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. executive Sandra D. van der Vaart, EVP, Corporate Affairs, received a grant of 6,382 shares of common stock on March 26, 2026. The award was earned under a performance plan covering the three-year period ended December 31, 2025.

To cover tax withholding obligations on this award, 2,722 shares were withheld at a price of $268.38 per share, rather than sold in the open market. After these transactions, she directly holds 6,238.9467 shares of Labcorp common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider van der Vaart Sandra D

Role EVP, Corporate Affairs

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,382	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,722	$268.38	$731K

Holdings After Transaction: Common Stock — 6,238.9467 shares (Direct)

Footnotes (2)

1. F1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
2. F2. Stock withholding to satisfy tax withholding obligations.

Key Figures

Performance shares granted: 6,382 shares Shares withheld for taxes: 2,722 shares Tax withholding price: $268.38 per share +3 more

6 metrics

Performance shares granted 6,382 shares Common stock award on March 26, 2026

Shares withheld for taxes 2,722 shares Tax withholding on performance award

Tax withholding price $268.38 per share Value used for stock withholding

Shares held after transactions 6,238.9467 shares Direct Labcorp common stock ownership

Gross shares acquired 6,382 shares Form 4 code A, grant/award acquisition

Shares used for tax liability 2,722 shares Form 4 code F, tax-withholding disposition

Key Terms

performance award, tax withholding obligations, grant, award, or other acquisition, tax-withholding disposition, +1 more

5 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025"

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

non-derivative financial

"transaction_type: non-derivative"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Labcorp (LH) report about Sandra D. van der Vaart’s recent share transactions?

Labcorp reported that EVP Sandra D. van der Vaart received a performance-based grant of 6,382 common shares. As part of the same event, 2,722 shares were withheld to cover taxes, leaving her with 6,238.9467 shares held directly after the transactions.

Was Sandra D. van der Vaart’s Labcorp (LH) Form 4 a market buy or sell?

The Form 4 shows no open‑market buying or selling. She acquired 6,382 shares through a performance award and 2,722 shares were withheld to satisfy tax obligations, meaning those shares were used for taxes rather than sold at her discretion.

What performance period did Sandra D. van der Vaart’s Labcorp (LH) share award cover?

The 6,382-share award relates to performance during a three‑year period ending December 31, 2025. The company notes the shares were acquired pursuant to a performance award granted on February 7, 2023, which vested based on results over that multi‑year timeframe.

How many Labcorp (LH) shares were withheld for taxes on Sandra D. van der Vaart’s award?

Labcorp withheld 2,722 shares of common stock to satisfy tax withholding obligations tied to the vested performance award. These shares were valued at $268.38 per share, reducing the net number of shares she retained from the grant while covering her related tax liability.

How many Labcorp (LH) shares does Sandra D. van der Vaart own after the Form 4 transactions?

Following the grant and tax withholding, Sandra D. van der Vaart directly holds 6,238.9467 shares of Labcorp common stock. This figure reflects the 6,382-share performance award minus the 2,722 shares withheld for taxes, as reported in the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/30/2026 - 12:49 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van der Vaart Sandra D

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Corporate Affairs

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2026		A(1)		6,382	A	$0	8,960.9467	D
Common Stock	03/26/2026		F(2)		2,722	D	$268.38	6,238.9467	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Sandra D. van der Vaart	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)